SCIENMAG: Medicine & Health

MARCH 21, 2024

In a mouse study, UCLA researchers tested a vaccine against the bacterium that causes melioidosis and found it was highly protective against the disease, which is endemic in many tropical areas, causing approximately 165,000 cases with 89,000 fatalities around the world each year. Credit: Photo courtesy of Christopher T.

Vaccine 60

Vaccine Disease Research 60

BioPharma Drive: Drug Pricing

OCTOBER 23, 2023

The clearance of the pentavalent shot Penbraya adds to Pfizer’s infectious disease portfolio as it adjusts to slumping COVID-19 vaccine sales.

FDA Approval 122

FDA Approval Vaccine FDA Disease 122

Drug Target Review

AUGUST 11, 2023

In a new development, a recent paper published in Biology Methods & Protocols by Oxford University Press has highlighted a promising avenue for enhancing vaccine efficacy against infectious pathogens like the COVID-19 virus. The implications of this finding are far-reaching, as it holds the potential to revolutionize vaccine design.

Vaccine 98

Vaccine Immune Response Bioinformatics Virus 98

Drugs.com

OCTOBER 6, 2023

5, 2023 -- Wallet-friendly cards showing proof of COVID vaccinations served a purpose early in the pandemic, but they’re on their way out. Centers for Disease Control and Prevention has stopped printing the cards, THURSDAY, Oct.

Vaccine 111

Vaccine Disease 111

Drug Discovery Today

JANUARY 2, 2024

Researchers from the Royal Veterinary College (RVC) and University of Oxford have led an innovative project investigating the progression of malaria infection and the role of the parasite to better aid the development of an effective malaria vaccine and significantly reduce rates of deaths from the disease.

Vaccine 113

Vaccine Disease Research 113

Drugs.com

AUGUST 21, 2023

21, 2023 -- Certain adult vaccines, including shingles and pneumonia shots, may also help seniors fight off Alzheimer's disease, new research reveals. Prior vaccination with the shingles vaccine, pneumococcus vaccine or the tetanus and. MONDAY, Aug.

Vaccine 98

Vaccine Disease Research 98

SCIENMAG: Medicine & Health

DECEMBER 14, 2023

WHAT: An effective HIV vaccine may need to prompt strong responses from immune cells called CD8+ T cells to protect people from acquiring HIV, according to a new study from researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and colleagues.

Vaccine 95

Vaccine Research Disease 95

SCIENMAG: Medicine & Health

JULY 27, 2023

OVX836 demonstrated positive safety and immunogenicity data across three dose levels A notable signal of protection of 84% was observed against symptomatic influenza infection Lyon, France – July 28, 2023 – Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating infectious viruses, today (..)

Vaccine 65

Vaccine Disease Virus 65

SCIENMAG: Medicine & Health

AUGUST 8, 2023

A booster vaccine using implant technology for koalas is being developed by QUT researchers in the fight against the deadly Chlamydia disease. Credit: QUT Media A booster vaccine using implant technology for koalas is being developed by QUT researchers in the fight against the deadly Chlamydia disease.

Disease 87

Disease Vaccine Research Engineering 87

The Pharma Data

MAY 5, 2022

In animal studies that mimic human exposures, an investigational COVID vaccine designed to be taken orally not only protects the host, but also decreases the airborne spread of the virus to other close contacts. The human vaccine is designed to be taken as a pill. The study, led by Duke researcher Stephanie N. Langel, Ph.D.,

Vaccine 52

Vaccine Disease Virus Science 52

Science Daily: Pharmacology News

AUGUST 31, 2023

A new study found that more than half of people who own dogs expressed some level of canine vaccine hesitancy -- i.e. skepticism about vaccinating their pets against rabies and other diseases.

Vaccine 99

Vaccine Disease 99

PLOS: DNA Science

OCTOBER 3, 2024

One of the oldest and most successful immunotherapies is simpler: a tamed version of a classic vaccine, against the infectious disease tuberculosis (TB). “BCG” is the “treatment” vaccine’s technical name, for Mycobacterium bovis Bacillus Calmette-Guérin. The approach worked.

Vaccine 52

Vaccine Immune Response DNA Treatment 52

Drugs.com

SEPTEMBER 7, 2023

7, 2023 -- While it doesn't prevent infection altogether, new research shows the mpox vaccine does reduces the severity of disease in those who fall ill from the virus. THURSDAY, Sept. An international team of scientists found that those people who.

Vaccine 85

Vaccine Virus International Disease 85

SCIENMAG: Medicine & Health

AUGUST 20, 2023

Research at a Glance: A Murdoch Children’s Research Institute-led review has found COVID-19 vaccines are effective against severe cases of the disease in children and adolescents.

Vaccine 75

Vaccine Virus Disease Research 75

The Pharma Data

APRIL 26, 2022

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. NYSE: PFE) today reported positive Phase 2 pediatric data for their Lyme disease vaccine candidate, VLA15.

Vaccine 52

Vaccine Disease Protein Expression Trials 52

BioPharma Drive: Drug Pricing

OCTOBER 8, 2024

Cumulatively, data showed the shot to be 63% effective across the three-year period. However, efficacy appeared to wane and GSK said it expects revaccination will eventually be needed.

Vaccine 60

Vaccine Disease 60

Drug Target Review

AUGUST 22, 2023

This Q&A explores how pre-clinical research is being used to identify potential therapies for Huntington’s disease, a devastating condition that currently lacks disease- modifying treatments. What makes the potential therapeutic for Huntington’s disease unique compared to other treatments?

Therapies 98

Therapies Disease Treatment RNA 98

SCIENMAG: Medicine & Health

FEBRUARY 14, 2024

WHAT: Women who receive an mRNA-based COVID-19 vaccination or booster during pregnancy can provide their infants with strong protection against symptomatic COVID-19 infection for at least six months after birth, according to a study from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

Vaccine 72

Vaccine Disease 72

The Pharma Data

SEPTEMBER 30, 2021

Anderson Professor of Chemical and Biomolecular Engineering, and his colleagues, are reporting in iScience the event of an intranasal subunit vaccine that gives durable local immunity against inhaled pathogens. A fundamental limitation of intramuscular vaccines is that they’re not designed to elicit mucosal immunity.

Vaccine 52

Vaccine Disease Immune Response Virus 52

Drugs.com

JUNE 29, 2023

THURSDAY, June 29, 2023 -- Americans ages 60 and up can get their vaccine for respiratory syncytial virus (RSV) this fall, the U.S. Centers for Disease Control and Prevention announced Thursday. On Thursday, Dr. Rochelle Walensky, the outgoing CDC.

Vaccine 116

Vaccine Virus Disease 116

The Pharma Data

JULY 21, 2021

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, and Pfizer Inc. at Month 7). Juan Carlos Jaramillo M.D., About VLA15.

Vaccine 52

Vaccine Disease Trials Protein Expression 52

Drugs.com

OCTOBER 27, 2023

26, 2023 -- A new vaccine recommended Wednesday by independent advisers to the U.S. Centers for Disease Control and Prevention could provide more comprehensive protection from meningitis. THURSDAY, Oct. The shot would protect against five types of.

Vaccine 75

Vaccine Disease 75

Drugs.com

OCTOBER 27, 2023

26, 2023 – High-risk men should still get their mpox vaccinations even after the ongoing outbreak ends, advisors to the U.S. Centers for Disease Control and Prevention recommended Wednesday. THURSDAY, Oct. That vulnerable group includes.

Vaccine 81

Vaccine Disease 81

BioPharma Drive: Drug Pricing

FEBRUARY 21, 2024

The Danish company scrapped a vaccine in Phase 1 testing and will exit oncology altogether, focusing instead on infectious disease research.

Vaccine 73

Vaccine Disease Research 73

BioPharma Drive: Drug Pricing

OCTOBER 3, 2023

The French vaccine giant will pay J&J $175 million to share rights to the experimental inoculation, which is currently in Phase 3 testing.

Vaccine 56

Vaccine Disease 56

PerkinElmer

MAY 28, 2020

Time is of the essence when it comes to the development of a vaccine for the novel infectious disease in our current pandemic. The world has changed due to its impact – and the race to discover a vaccine is crucial for our return to normalcy.

Vaccine 52

Vaccine Disease Virus Small Molecule 52

SCIENMAG: Medicine & Health

SEPTEMBER 15, 2023

Enrollment in a Phase 1 trial of a new investigational universal influenza vaccine candidate has begun at the National Institutes of Health’s Clinical Center in Bethesda, Maryland.

Vaccine 52

Vaccine Clinical Trials Trials Disease 52

SCIENMAG: Medicine & Health

JULY 24, 2023

Centers for Disease Control and Prevention’s VISION Network, has determined both the number of adults needed to be vaccinated to prevent one COVID-19 associated hospitalization […] An analysis of real-world data from more than 1.2

Hospitals 84

Hospitals Vaccine Disease 84

FDA Law Blog: Drug Discovery

JUNE 12, 2024

Sasinowski — Hyman, Phelps & McNamara (HPM) would like to congratulate the 7 rare disease programs selected for the inaugural class of the FDA’s “Support for clinical Trials Advancing Rare disease Treatment” (START) pilot program.

Disease 59

Disease Clinical Trials FDA Clinical Development 59

The Pharma Data

MARCH 8, 2021

Valneva SE (“Valneva”), a specialty vaccine company focused on prevention of diseases with major unmet needs, and Pfizer Inc. It will compare the three-dose vaccination schedule (Month 0-2-6) with a two-dose schedule (Month 0-6). “We We are excited to be part of the Lyme disease vaccine development program with Valneva.

Vaccine 52

Vaccine Disease Protein Expression Trials 52

Drugs.com

SEPTEMBER 16, 2024

16, 2024 -- People should prepare for the fall cold and flu season by getting the updated influenza and COVID-19 vaccinations, an infectious diseases expert says.“When When my patients ask me if they should be getting a COVID vaccine this y. MONDAY, Sept.

Vaccine 116

Vaccine Disease 116

Drugs.com

AUGUST 24, 2023

24, 2023 -- For the first time in a decade, the rate at which American adolescents received the human papillomavirus (HPV) vaccine has not increased, new data show. Centers for Disease Control and. THURSDAY, Aug. Current guidelines from the U.S.

Vaccine 52

Vaccine Disease 52

BioPharma Drive: Drug Pricing

OCTOBER 7, 2024

The development of cancer vaccines has provided some hope in the battle against cancer worldwide; however, there are still many challenges to overcome when developing these life-saving treatments.

Disease 52

Disease Trials Vaccine Treatment 52

PPD

MAY 11, 2023

The global COVID-19 pandemic increased awareness of the importance of vaccine development — both for drug developers and the public. The speed at which COVID-19 vaccines were developed was remarkable, but like most newly developed vaccines, there was variation among who could receive the shots and when.

Vaccine 52

Vaccine Clinical Trials Long-Term Care Facilities Trials 52

Drugs.com

JANUARY 12, 2024

12, 2024 -- Sickle cell disease is one of many chronic health conditions that dramatically increases the risk of hospitalization and death in people infected by COVID-19.Unfortunately, Unfortunately, folks with sickle cell disease are much less. FRIDAY, Jan.

Vaccine 141

Vaccine Hospitals Disease 141

SCIENMAG: Medicine & Health

JUNE 12, 2023

Peer-reviewed / Randomised Controlled Trial / People Study of healthy US adults found that a single dose of the VLA1553 vaccine candidate was generally safe, well tolerated and provokes an immune response.

Immune Response 66

Immune Response Vaccine Trials Disease 66

Drugs.com

MARCH 19, 2024

Centers for Disease Control and. TUESDAY, March 19, 2024 -- Two of America's leading health organizations are highlighting a global rise in measles cases as yet another reason for families to make sure they get the measles vaccine.The U.S.

Vaccine 119

Vaccine Disease 119